Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science
0 Comments
Prospero Health is continuing its national expansion efforts. The home-based health care company announced Monday that it’s now entering the Southern California market. Founded in 2019, Boston-based Prospero Health is a physician-led home-based health care company that provides supportive care to people with advanced illnesses. As of March 2021, Prospero serves more than 9,000 patients
0 Comments
Dive Brief: Primary care network One Medical pushed back on allegations it gave the coronavirus vaccine to ineligible patients along with the release of fourth-quarter and full-year financial results late last week, beating Wall Street expectations with strong topline and membership growth. Numerous reports, including one from NPR published Wednesday, found the San Francisco-based company
0 Comments
Total health care spending for people with private health insurance would be an estimated $352 billion lower in 2021 if private insurers used Medicare rates to pay hospitals and other health care providers, rather than the substantially higher rates they currently pay, a new KFF analysis finds. That would represent a 41 percent decrease from
0 Comments
As patient care becomes more dynamic with the occurrence of COVID-19 and the rising cases of chronic conditions in the US, providers need more resources and information at the point-of-care to help drive better patient care. We held a series of medical insight sessions including providers from across the spectrum of care including health systems,
0 Comments
The cost of health care is becoming less affordable for both privately insured individuals and employers who offer health insurance coverage. Long-standing concerns about high and rising health care costs in the United States have been recently exacerbated by the COVID-19 pandemic, which has increased financial pressure on many employers and individuals and led to
0 Comments
A U.S. advisory panel has endorsed the new one-dose COVID-19 vaccine from Johnson & Johnson as a third option to bolster the national effort against the coronavirus pandemic. Advisers to the Centers for Disease Control and Prevention voted overwhelmingly to recommend the vaccine for adults 18 years old and up. The ruling followed emergency clearance
0 Comments
Johnson & Johnson Coronavirus vaccine illustration Dado Ruvic | Reuters An advisory panel to the Centers for Disease Control and Prevention voted unanimously Sunday to recommend the use of Johnson & Johnson‘s one-shot Covid-19 vaccine as the federal government prepares to ship out millions of doses this week. Once CDC Director Dr. Rochelle Walensky accepts
0 Comments
Just five weeks ago, Los Angeles County was conducting more than 350,000 weekly coronavirus tests, including at a massive drive-thru site at Dodger Stadium, as health workers raced to contain the worst COVID-19 hotspot in the U.S. Now, county officials say testing has nearly collapsed. More than 180 government-supported sites are operating at only a
0 Comments
The Food and Drug Administration has approved Johnson & Johnson‘s Covid-19 vaccine for emergency use, giving the United States a third tool to fight the pandemic as highly contagious variants start to take root across the country. The FDA’s emergency use authorization Saturday kickstarts the federal government’s plan to distribute nearly 4 million doses of
0 Comments
Lorie Turner is using her entrepreneurial experience and 30-year nursing career to get vulnerable Detroiters on the east side vaccinated for COVID-19. The 57-year-old nurse practitioner opened a not-for-profit medical clinic called God’s Path Community Services in September — a life decision made after her husband nearly died of COVID-19. She’s using the site to
0 Comments
Over the last few months, Addus HomeCare Corporation (Nasdaq: ADUS) has had to deal with a challenging legislative environment and significant COVID-19 surges that have affected clients and caregivers alike. Still, the Frisco, Texas-based in-home care provider is maintaining its course, particularly when it comes to M&A activity in 2021. “We continue to evaluate and
0 Comments